Two years ago in August, Signals hosted a blog carnival and it was such a success we’ve been doing it ever since.
If you are scratching your head at the term “blog carnival” and wondering if this website has been hacked, I recommend you read the section below. If you followed the fun in 2017 and/or 2016, you may want to skip ahead to the section where the topic is revealed.
Read this section if you are confused
A blog carnival is a collection of posts from influential bloggers all centred around one theme and shared through a host blog, as well as the bloggers’ sites. It’s a fun and novel way to shine a spotlight on regenerative medicine, including cell and gene therapies, and provocative ideas within our community. As far as I know, Signals is still the only blog hosting blog carnivals on this industry.
Readers will have a chance to hop from post to post, just like one would between the booths at a carnival, and absorb a wide range of opinions and views. Sadly, there is no candy floss involved – not even the regenerative medicine kind.
In 2017, the topic was “Right to Try,” something that heated up in 2018 when U.S. president Donald Trump signed the legislation and made it law. You can read our take on the issue here.
In our inaugural year, we celebrated the 10-year anniversary of iPSCs. Much less controversial, but equally compelling – not to mention interesting to see how all the bloggers approached the topic differently.
You can expect that same variety this year too.
If you’re still looking for more on blog carnivals, read this.
Read this section for details about this year’s blog carnival
The complete list of this year’s bloggers is still being finalized, but there are some treats in store. In addition to inviting some well-known bloggers from Canada and the U.S., along with some popular Signals’ contributors, I’ve asked some thought leaders to lend their opinions to the conversation. For example, physician Sven Kili, VP and Head of Cell & Gene Therapy Development at GSK, has agreed to share his thoughts on this year’s theme.
Which leads me to the topic:
Has the regenerative medicine (cell therapy and gene therapy included) industry come of age? I won’t say more at this time, but there will be lots to contribute in three weeks. Please join us on Wednesday, August 29. As always, your input is also invited. After reading the blogs, let us know whether you think the industry has finally come of age.
For a flavour of what’s to come, I suggest you watch these experts as they discuss whether the industry has met expectations, in a video produced by RegMedNet during the 2018 ISCT conference in Montreal, Canada. Video three (of three), shown here, covers preservation and supply chain issues, but if you jump ahead to 17:35, the discussion about expectations begins. (There’s a link on the page to watch all three videos.)
Stacey Johnson
Latest posts by Stacey Johnson (see all)
- Right Turn: #pinksocks, diabetes news and other ramblings - June 24, 2025
- Right Turn: Some takeaways from Advanced Therapies Week 2025 - January 31, 2025
- Right Turn: The top 10 most-read blog posts in 2024 - January 2, 2025
Comments